Published in Blood Weekly, January 9th, 2003
John R. Haines, president and CEO of Anthrogenesis, stated: "We are very pleased about this license agreement with PharmaStem. Importantly, parents who entrust their children's cord blood to our Lifebank division can be secure in the knowledge that we are the first company to obtain a license under the important...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.